COVID-19 Immunotherapy- Novel Humanized 47D11 Monoclonal Antibody

Basma H Marghani
Additional contact information
Basma H Marghani: Department of Physiology, Faculty of Veterinary Medicine, Mansoura University, Egypt

Biomedical Journal of Scientific & Technical Research, 2020, vol. 29, issue 4, 22597-22603

Abstract: SARS-CoV-2 was appeared firstly in Wuhan, China in December 2019, then spread rapidly to the other countries all over the world...

Keywords: COVID-19; Immunotherapy; Full-Length Humanized Monoclonal Antibodies; ACE Inhibitor (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.004828.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.004828.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:29:y:2020:i:4:p:22597-22603

DOI: 10.26717/BJSTR.2020.29.004828

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().